Clinical Trials Browser

INDUSTRY × Lapatinib × Gynecologic × Clear all

NCT00430781 2015-05-08

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Phase 2 Completed

228 enrolled 21 charts

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT00447226 2012-06-12

Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists

Phase 2 Terminated

32 enrolled 10 charts

GastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms